HAVCR2 and Hyperglycemia: Recent research has demonstrated that hyperglycemia-driven metabolic stress directly impairs immune checkpoint pathways, including PD-1, PD-L1, CTLA-4, TIM-3, and LAG-3, by altering T-cell bioenergetics, mitochondrial function, and redox balance [3].